Abstract
Pangamic acid is shown to be a mixture of variable composition. Criteria of identity and methods of analysis are described for five pharmaceutical dosage forms. Experimental results indicate that the products are not uniform in composition and that composition does not conform to label claims. No satisfactory preclinical drug application for any such preparation has so far been submitted to the Food and Drug Directorate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AIZAWA T., HAMAYA S. Cerebral sclerosis and cerebral circulation. Jpn Heart J. 1961 Apr;2:133–146. doi: 10.1536/ihj.2.133. [DOI] [PubMed] [Google Scholar]
- BEARD H. H., WOFFORD G. The effect of administration of synthetic vitamin B15 H8 upon creatine formation in the rat. Exp Med Surg. 1956;14(2-3):169–173. [PubMed] [Google Scholar]
- BERTELLI A., CASENTINI S. Il dicloroacetato di diisopropilammonio come molecola responsabile di alcune attività farmacologiche attribuite al cosiddetto acido pangamico. Boll Soc Ital Biol Sper. 1958 Nov 30;34(22):1532–1534. [PubMed] [Google Scholar]
- BERTELLI A., CASENTINI S. Sullo stimolo surrenalico da acido pangamico e acido salicilico associati. Boll Soc Ital Biol Sper. 1957 Jun;33(6):907–909. [PubMed] [Google Scholar]
- LEVI L., WALKER G. C., PUGSLEY L. I. QUALITY CONTROL OF PHARMACEUTICALS. Can Med Assoc J. 1964 Oct 10;91:781–785. [PMC free article] [PubMed] [Google Scholar]
- MARSHALL F. N., ADAMSON R. H., LONG J. P. Some pharmacologic properties of pangamic acid (vitamin B-15). Proc Soc Exp Biol Med. 1961 Jun;107:420–422. doi: 10.3181/00379727-107-26644. [DOI] [PubMed] [Google Scholar]